Vanguard Group
NTUS

Vanguard Group’s Natus Medical Inc NTUS Stock Holding History

Vanguard Group’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-3,133,946
Closed -$103M – 4652
2022
Q2 		$103M Buy
3,133,946
+75,073
+2% +$2.37M ﹤0.01% 1810
2022
Q1 		$80.4M Buy
3,058,873
+14,353
+0.5% +$350K ﹤0.01% 2059
2021
Q4 		$72.2M Buy
3,044,520
+80,285
+3% +$1.98M ﹤0.01% 2148
2021
Q3 		$74.3M Buy
2,964,235
+8,829
+0.3% +$225K ﹤0.01% 2151
2021
Q2 		$76.8M Buy
2,955,406
+76,373
+3% +$2.08M ﹤0.01% 2135
2021
Q1 		$73.7M Buy
2,879,033
+90,031
+3% +$2.31M ﹤0.01% 2110
2020
Q4 		$55.9M Buy
2,789,002
+100,426
+4% +$1.97M ﹤0.01% 2139
2020
Q3 		$46.1M Sell
2,688,576
-118,808
-4% -$2.25M ﹤0.01% 2063
2020
Q2 		$61.3M Sell
2,807,384
-87,335
-3% -$2M ﹤0.01% 1906
2020
Q1 		$67M Buy
2,894,719
+108,050
+4% +$3.14M ﹤0.01% 1722
2019
Q4 		$91.9M Sell
2,786,669
-79,315
-3% -$2.54M ﹤0.01% 1814
2019
Q3 		$91.3M Buy
2,865,984
+73,448
+3% +$2.14M ﹤0.01% 1778
2019
Q2 		$71.7M Buy
2,792,536
+31,136
+1% +$793K ﹤0.01% 1925
2019
Q1 		$70.1M Buy
2,761,400
+50,429
+2% +$1.5M ﹤0.01% 1923
2018
Q4 		$92.3M Buy
2,710,971
+98,539
+4% +$3.2M ﹤0.01% 1716
2018
Q3 		$93.1M Buy
2,612,432
+58,239
+2% +$2.06M ﹤0.01% 1839
2018
Q2 		$88.1M Buy
2,554,193
+229,921
+10% +$8.06M ﹤0.01% 1845
2018
Q1 		$78.2M Buy
2,324,272
+79,208
+4% +$2.51M ﹤0.01% 1846
2017
Q4 		$85.8M Sell
2,245,064
-128,071
-5% -$5.11M ﹤0.01% 1800
2017
Q3 		$89M Buy
2,373,135
+31,589
+1% +$1.11M ﹤0.01% 1773
2017
Q2 		$87.3M Buy
2,341,546
+66,676
+3% +$2.41M ﹤0.01% 1747
2017
Q1 		$89.3M Buy
2,274,870
+105,008
+5% +$3.94M ﹤0.01% 1717
2016
Q4 		$75.5M Buy
2,169,862
+47,392
+2% +$1.86M ﹤0.01% 1776
2016
Q3 		$83.4M Buy
2,122,470
+35,888
+2% +$1.43M ﹤0.01% 1679
2016
Q2 		$78.9M Sell
2,086,582
-165,845
-7% -$5.55M ﹤0.01% 1664
2016
Q1 		$86.6M Sell
2,252,427
-277,074
-11% -$10.3M 0.01% 1572
2015
Q4 		$122M Buy
2,529,501
+497,360
+24% +$23M 0.01% 1329
2015
Q3 		$80.2M Buy
2,032,141
+90,608
+5% +$3.85M 0.01% 1593
2015
Q2 		$82.6M Buy
1,941,533
+125,692
+7% +$5.01M 0.01% 1648
2015
Q1 		$71.7M Buy
1,815,841
+110,941
+7% +$4.09M ﹤0.01% 1728
2014
Q4 		$61.4M Buy
1,704,900
+79,428
+5% +$2.67M ﹤0.01% 1719
2014
Q3 		$48M Buy
1,625,472
+193,993
+14% +$5.35M ﹤0.01% 1817
2014
Q2 		$36M Buy
1,431,479
+296,441
+26% +$7.33M ﹤0.01% 1989
2014
Q1 		$29.3M Buy
1,135,038
+38,319
+3% +$966K ﹤0.01% 2054
2013
Q4 		$24.7M Buy
1,096,719
+17,140
+2% +$331K ﹤0.01% 2093
2013
Q3 		$15.3M Buy
1,079,579
+15,234
+1% +$204K ﹤0.01% 2209
2013
Q2 		$14.5M Buy
+1,064,345
New +$14.5M ﹤0.01% 2176

Other funds holding NTUS

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

Vanguard Group's NTUS Position: Q3 2022 in Review

Vanguard Group sold out of Natus Medical Inc (NTUS) in Q3 2022, closing a stake of 3,133,946 shares — an estimated $103M sold.

Vanguard Group first reported a position in NTUS in Q2 2013 and held it in 37 quarters. The position peaked at $122M in Q4 2015. 1 fund tracked by Wall St. Rank holds NTUS as of Q3 2022.

  • Vanguard Group reported no remaining Natus Medical Inc position as of Q3 2022 after selling out during the quarter.
  • Vanguard Group sold 3,133,946 Natus Medical Inc shares in Q3 2022, an estimated $103M.
  • Vanguard Group first reported a position in Natus Medical Inc in Q2 2013 and held it in 37 quarters.
  • Vanguard Group's Natus Medical Inc position peaked at $122M in Q4 2015.
  • 1 fund tracked by Wall St. Rank held Natus Medical Inc as of Q3 2022.

Based on Vanguard Group's 13F filing for Q3 2022, filed 14 Nov 2022.